Biofrontera Inc. Warrants (BFRIW)

• Market cap: $801K
• 1 day: 0.00%
• 5 days: -18.72%
• 1 month: 96.73%
• 3 months: -24.37%
• 6 months: 18.50%
• Year to date: 27.18%
• 1 year: 72.00%
• 5 years: -93.00%
• 10 years: -93.00%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.

Employees: 93

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

20% more funds holding

Funds holding: 5 [Q4 2024] → 6 (+1) [Q1 2025]

5% more capital invested

Capital invested by funds: $11.8K [Q4 2024] → $12.4K (+$594) [Q1 2025]

0.7% less ownership

Funds ownership: 2.98% [Q4 2024] → 2.28% (-0.7%) [Q1 2025]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2